An inhibitory effect of beauvericin, a cyclodepsipeptide, on a high K
+-induced contraction in guinea-pig taenia coli was compared with those of verapamil, an organic Ca
2+ antagonist, and monensin, an inhibitor of mitochondrial respiration. Beauvericin (10
-5 M), verapamil (5×10
-7 M) or monensin (10
-6 M) markedly inhibited the tonic contraction, while these drugs showed less effect on the phasic contraction. Beauvericin at a lower concentration (10
-6 M) competitively inhibited the Ca
2+-induced contraction in depolarized muscle, whereas higher concentrations (3×10
-6 or 10
-5 M) non-competitively inhibited this contraction. Verapamil (10
-8-5×10
-7 M) competitively inhibited and monensin at a low concentration (10
-7 M) non-competitively inhibited this contraction. A contraction induced by 0.5 mM Ca
2+ was inhibited by beauvericin with an IC50 (concentration needed for 50% inhibition) of 2.8×10
-7 M, verapamil with an IC50 of 2.9×10
-8 M, and nifedipine with an IC50 of 1.8×10
-9 M. 10
-6 M CGP 28392, a Ca
2+ channel facilitator, increased the IC50 of beauvericin, verapamil or nifedipine. Although the inhibitory effect of monensin (10
-7-10
-6 M) on the high K
+-induced contraction was reduced under hypoxia, the effects of beauvericin (10
-7-10
-5 M) and verapamil (10
-8-10
-7 M) were not modified. Beauvericin (10
-5 M) changed neither the intracellular Na
+ and K
+ contents of the depolarized muscle nor the Ca
2+-induced contraction in the chemically skinned taenia coll. These results suggest that the inhibitory action of beauvericin (10
-5 M) on the high K
+-induced tonic contraction is due to the non-competitive inhibition of Ca
2+ entry through the voltage-dependent Ca
2+ channel of the intestinal smooth muscle cell.
View full abstract